Phanstiel S. Louise's Form 4 filing
Myriad Genetics Inc (MYGN) · filed Feb 27, 2026
- Accession no.
- 0001471518-26-000002
- Filed
- Feb 27, 2026
- Trade date
- Feb 25-27, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $494.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Phanstiel S. LouiseCIK 0001471518 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Common Stock | PPurchaseAcquired | +6,100 | $4.74 | +$28,914 | 183,544 | Direct | |
| Feb 26, 2026 | Common Stock | PPurchaseAcquired | +50,407 | $4.80 | +$241,953.6 | 233,951 | Direct | |
| Feb 27, 2026 | Common Stock | PPurchaseAcquired | +48,000 | $4.66 | +$223,680 | 281,951 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.